2012 Q4 Form 10-K Financial Statement

#000114420413019816 Filed on April 03, 2013

View on sec.gov

Income Statement

Concept 2012 Q4 2012 2011 Q4
Revenue $600.0K $1.343M $40.00K
YoY Change 1400.0% 3622.31%
Cost Of Revenue $60.00K $319.3K $10.00K
YoY Change 500.0% 2615.12%
Gross Profit $550.0K $1.024M $20.00K
YoY Change 2650.0% 4109.38%
Gross Profit Margin 91.67% 76.22% 50.0%
Selling, General & Admin $680.0K $1.355M $500.0K
YoY Change 36.0% 10.12% 150.0%
% of Gross Profit 123.64% 132.35% 2500.0%
Research & Development $680.0K $2.532M $490.0K
YoY Change 38.78% -12.32% 145.0%
% of Gross Profit 123.64% 247.4% 2450.0%
Depreciation & Amortization $20.00K $29.32K -$10.00K
YoY Change -300.0% 23.43% -200.0%
% of Gross Profit 3.64% 2.86% -50.0%
Operating Expenses $1.360M $4.514M $990.0K
YoY Change 37.37% 1.2% 147.5%
Operating Profit -$810.0K -$3.491M -$970.0K
YoY Change -16.49% -21.32%
Interest Expense -$120.0K -$564.4K -$230.0K
YoY Change -47.83% -45.98% 228.57%
% of Operating Profit
Other Income/Expense, Net -$564.4K
YoY Change -45.98%
Pretax Income -$930.0K -$4.055M -$1.200M
YoY Change -22.5% -26.02% 150.0%
Income Tax -$390.0K -$391.8K $0.00
% Of Pretax Income
Net Earnings -$540.0K -$3.664M -$1.200M
YoY Change -55.0% -33.17% 150.0%
Net Earnings / Revenue -90.0% -272.8% -3000.0%
Basic Earnings Per Share
Diluted Earnings Per Share -$60.34K -$461.5K -$166.2K
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept 2012 Q4 2012 2011 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.700M $1.730M $1.200M
YoY Change 41.67% 45.38% 9.09%
Cash & Equivalents $1.729M $1.730M $1.187M
Short-Term Investments
Other Short-Term Assets $500.0K $480.0K $0.00
YoY Change 1100.0% -100.0%
Inventory $682.4K $680.0K $431.0K
Prepaid Expenses
Receivables $100.0K $50.00K $36.08K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $2.940M $2.940M $1.697M
YoY Change 73.17% 72.94% 21.25%
LONG-TERM ASSETS
Property, Plant & Equipment $145.6K $150.0K $155.1K
YoY Change -6.11% -6.25% 55.07%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $254.2K $50.00K $270.0K
YoY Change -5.84% -16.67% -10.0%
Total Long-Term Assets $399.8K $400.0K $425.1K
YoY Change -5.94% -4.76% 6.27%
TOTAL ASSETS
Total Short-Term Assets $2.940M $2.940M $1.697M
Total Long-Term Assets $399.8K $400.0K $425.1K
Total Assets $3.339M $3.340M $2.123M
YoY Change 57.33% 57.55% 17.92%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $800.7K $800.0K $675.2K
YoY Change 18.59% 17.65% -15.61%
Accrued Expenses $300.0K $350.0K $600.0K
YoY Change -50.0% -37.5% 50.0%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $900.0K $930.0K $300.0K
YoY Change 200.0% 220.69%
Total Short-Term Liabilities $2.077M $2.080M $1.528M
YoY Change 35.92% 35.95% 27.33%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $300.0K
YoY Change -100.0% -100.0% -72.73%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $276.3K
YoY Change -100.0% -74.89%
TOTAL LIABILITIES
Total Short-Term Liabilities $2.077M $2.080M $1.528M
Total Long-Term Liabilities $0.00 $276.3K
Total Liabilities $2.077M $2.080M $1.804M
YoY Change 15.11% 15.56% -21.56%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock $215.0K $177.6K
YoY Change 21.02%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$11.63M $1.260M -$10.09M
YoY Change
Total Liabilities & Shareholders Equity $3.339M $3.340M $2.123M
YoY Change 57.33% 57.55% 17.92%

Cashflow Statement

Concept 2012 Q4 2012 2011 Q4
OPERATING ACTIVITIES
Net Income -$540.0K -$3.664M -$1.200M
YoY Change -55.0% -33.17% 150.0%
Depreciation, Depletion And Amortization $20.00K $29.32K -$10.00K
YoY Change -300.0% 23.43% -200.0%
Cash From Operating Activities -$770.0K -$3.616M -$1.110M
YoY Change -30.63% -5.54% 65.67%
INVESTING ACTIVITIES
Capital Expenditures -$20.00K $19.85K $0.00
YoY Change -42.75% -100.0%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 $0.00
YoY Change
Cash From Investing Activities -$20.00K -$38.81K $0.00
YoY Change -26.07% -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $0.00
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 460.0K $4.211M 0.000
YoY Change 4.95% -100.0%
NET CHANGE
Cash From Operating Activities -770.0K -$3.616M -1.110M
Cash From Investing Activities -20.00K -$38.81K 0.000
Cash From Financing Activities 460.0K $4.211M 0.000
Net Change In Cash -330.0K $555.4K -1.110M
YoY Change -70.27% 323.99% -482.76%
FREE CASH FLOW
Cash From Operating Activities -$770.0K -$3.616M -$1.110M
Capital Expenditures -$20.00K $19.85K $0.00
Free Cash Flow -$750.0K -$3.636M -$1.110M
YoY Change -32.43% -5.87% 113.46%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Service Management Costs
ServiceManagementCosts
1334285 USD
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.28
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.019
CY2012Q4 ctso Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
349841 USD
CY2011Q4 ctso Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
558466 USD
CY2005 ctso Adjustments To Additional Paid In Capital Equity Investments Transactions
AdjustmentsToAdditionalPaidInCapitalEquityInvestmentsTransactions
USD
CY2006 ctso Adjustments To Additional Paid In Capital Option Issued
AdjustmentsToAdditionalPaidInCapitalOptionIssued
143352 USD
CY2007 ctso Adjustments To Additional Paid In Capital Option Issued
AdjustmentsToAdditionalPaidInCapitalOptionIssued
498955 USD
CY2012 ctso Adjustments To Additional Paid In Capital Warrants Modified
AdjustmentsToAdditionalPaidInCapitalWarrantsModified
10606 USD
CY2009 ctso Adjustments To Additional Paid In Capital Warrants Modified
AdjustmentsToAdditionalPaidInCapitalWarrantsModified
14885 USD
CY2006 ctso Adjustment To Additional Paid In Capital Merger Transaction
AdjustmentToAdditionalPaidInCapitalMergerTransaction
1000000 USD
CY1999 ctso Adjustment To Common Stock Issued
AdjustmentToCommonStockIssued
88363 USD
CY2000 ctso Adjustment To Common Stock Issued
AdjustmentToCommonStockIssued
1070740 USD
CY2001 ctso Adjustment To Common Stock Issued
AdjustmentToCommonStockIssued
161073 USD
CY2002 ctso Adjustment To Common Stock Issued
AdjustmentToCommonStockIssued
156073 USD
CY2003 ctso Adjustment To Common Stock Issued
AdjustmentToCommonStockIssued
16624 USD
CY2011Q1 ctso Aggregate Debt Or Equity Financing Amount
AggregateDebtOrEquityFinancingAmount
750000 USD
CY2012Q1 ctso Aggregate Debt Or Equity Financing Amount
AggregateDebtOrEquityFinancingAmount
750000 USD
CY1999 ctso Amortization Of Deferred Stock Based Compensation
AmortizationOfDeferredStockBasedCompensation
15667 USD
CY2000 ctso Amortization Of Deferred Stock Based Compensation
AmortizationOfDeferredStockBasedCompensation
46772 USD
CY2001 ctso Amortization Of Deferred Stock Based Compensation
AmortizationOfDeferredStockBasedCompensation
12499 USD
ctso Capital Contributions
CapitalContributions
1143487 USD
CY1998 ctso Capital Contributions
CapitalContributions
2518236 USD
CY1999 ctso Capital Contributions
CapitalContributions
1382872 USD
CY2000 ctso Capital Contributions
CapitalContributions
14407916 USD
CY2001 ctso Capital Contributions
CapitalContributions
13411509 USD
CY2002 ctso Capital Contributions
CapitalContributions
6739189 USD
CY2003 ctso Capital Contributions
CapitalContributions
4067250 USD
CY2004 ctso Capital Contributions
CapitalContributions
512555 USD
CY2005 ctso Capital Contributions
CapitalContributions
92287 USD
CY2012 ctso Change In Fair Value Of Management Units
ChangeInFairValueOfManagementUnits
USD
CY2011 ctso Change In Fair Value Of Management Units
ChangeInFairValueOfManagementUnits
USD
ctso Change In Fair Value Of Management Units
ChangeInFairValueOfManagementUnits
278087 USD
CY2003 ctso Changes In Fair Value Of Noncontrolling Interests
ChangesInFairValueOfNoncontrollingInterests
2952474 USD
CY2004 ctso Changes In Fair Value Of Noncontrolling Interests
ChangesInFairValueOfNoncontrollingInterests
-2396291 USD
CY2005 ctso Changes In Fair Value Of Noncontrolling Interests
ChangesInFairValueOfNoncontrollingInterests
-14551 USD
CY2012 ctso Common Stock Issued As Inducement To Convert Convertible Notes Payable And Accrued Interest
CommonStockIssuedAsInducementToConvertConvertibleNotesPayableAndAccruedInterest
USD
CY2011 ctso Common Stock Issued As Inducement To Convert Convertible Notes Payable And Accrued Interest
CommonStockIssuedAsInducementToConvertConvertibleNotesPayableAndAccruedInterest
USD
ctso Common Stock Issued As Inducement To Convert Convertible Notes Payable And Accrued Interest
CommonStockIssuedAsInducementToConvertConvertibleNotesPayableAndAccruedInterest
3351961 USD
ctso Common Stock Issued Value Subscriptions
CommonStockIssuedValueSubscriptions
440000 USD
CY1998 ctso Common Stock Issued Value Subscriptions
CommonStockIssuedValueSubscriptions
50000 USD
CY1999 ctso Common Stock Issued Value Subscriptions
CommonStockIssuedValueSubscriptions
100000 USD
CY2011 ctso Management Units Issued
ManagementUnitsIssued
USD
ctso Management Units Issued
ManagementUnitsIssued
437206 USD
CY2011 ctso Debt Discount
DebtDiscount
1250000 USD
ctso Debt Discount
DebtDiscount
1644205 USD
CY1999 ctso Deferred Compensation Obligation
DeferredCompensationObligation
USD
CY2000 ctso Deferred Compensation Obligation
DeferredCompensationObligation
USD
CY1998 ctso Common Stock Options Granted Value
CommonStockOptionsGrantedValue
1671 USD
CY2002 ctso Common Stock Options Granted Value
CommonStockOptionsGrantedValue
176250 USD
CY2003 ctso Common Stock Options Granted Value
CommonStockOptionsGrantedValue
65681 USD
CY2001 ctso Common Stock Options Granted Value Employee
CommonStockOptionsGrantedValueEmployee
2847 USD
CY2002 ctso Common Stock Options Granted Value Employee
CommonStockOptionsGrantedValueEmployee
2847 USD
CY2011Q1 ctso Company Value Pre Money Fully Diluted Threshold
CompanyValuePreMoneyFullyDilutedThreshold
35000000 USD
CY2012 ctso Consulting Fees
ConsultingFees
USD
CY2011 ctso Consulting Fees
ConsultingFees
USD
ctso Consulting Fees
ConsultingFees
237836 USD
CY2012Q4 ctso Convertible Notes Current Unamortized Discount
ConvertibleNotesCurrentUnamortizedDiscount
178775 USD
CY2011Q4 ctso Convertible Notes Current Unamortized Discount
ConvertibleNotesCurrentUnamortizedDiscount
53677 USD
CY2012Q4 ctso Convertible Notes Noncurrent Unamortized Discount
ConvertibleNotesNoncurrentUnamortizedDiscount
0 USD
CY2011Q4 ctso Convertible Notes Noncurrent Unamortized Discount
ConvertibleNotesNoncurrentUnamortizedDiscount
508750 USD
CY2012 ctso Debt Discount
DebtDiscount
87400 USD
CY2008 ctso Dividends Preferred Stock Series B
DividendsPreferredStockSeriesB
-262717 USD
CY2012 ctso Issuance Of Common Stock In Exchange For Convertible Notes Value
IssuanceOfCommonStockInExchangeForConvertibleNotesValue
798911 USD
CY2011 ctso Issuance Of Common Stock In Exchange For Convertible Notes Value
IssuanceOfCommonStockInExchangeForConvertibleNotesValue
1515130 USD
CY2002 ctso Issuance Of Common Stock In Exchange For Convertible Notes Value
IssuanceOfCommonStockInExchangeForConvertibleNotesValue
-1350828 USD
CY2003 ctso Issuance Of Common Stock In Exchange For Convertible Notes Value
IssuanceOfCommonStockInExchangeForConvertibleNotesValue
-281340 USD
CY2005 ctso Issuance Of Common Stock In Exchange For Convertible Notes Value
IssuanceOfCommonStockInExchangeForConvertibleNotesValue
51565 USD
CY2006 ctso Issuance Of Common Stock In Exchange For Convertible Notes Value
IssuanceOfCommonStockInExchangeForConvertibleNotesValue
11382110 USD
CY2007 ctso Issuance Of Common Stock Value Dividends And Interest
IssuanceOfCommonStockValueDividendsAndInterest
361496 USD
CY2012 ctso Issuance Of Common Stock Value In Settlement Of Accounts Payable
IssuanceOfCommonStockValueInSettlementOfAccountsPayable
USD
CY2011 ctso Issuance Of Common Stock Value In Settlement Of Accounts Payable
IssuanceOfCommonStockValueInSettlementOfAccountsPayable
5000 USD
CY2005 ctso Issuance Of Common Stock Value In Settlement Of Accounts Payable
IssuanceOfCommonStockValueInSettlementOfAccountsPayable
836319 USD
CY2006 ctso Issuance Of Common Stock Value In Settlement Of Accounts Payable
IssuanceOfCommonStockValueInSettlementOfAccountsPayable
587814 USD
CY2007 ctso Issuance Of Common Stock Value In Settlement Of Accounts Payable
IssuanceOfCommonStockValueInSettlementOfAccountsPayable
23002 USD
CY2012 ctso Management Units Issued
ManagementUnitsIssued
USD
CY2012Q4 ctso Number Of Patents Issued
NumberOfPatentsIssued
32
CY2012 ctso Preferred Dividends Accrued Not Yet Paid
PreferredDividendsAccruedNotYetPaid
2511412 USD
CY2011 ctso Preferred Dividends Accrued Not Yet Paid
PreferredDividendsAccruedNotYetPaid
3087044 USD
ctso Preferred Dividends Accrued Not Yet Paid
PreferredDividendsAccruedNotYetPaid
10922035 USD
CY2012 ctso Preferred Stock Additional Shares Available For Issuance
PreferredStockAdditionalSharesAvailableForIssuance
87800000
CY2012 ctso Proceeds From Sale Of Net Operating Loss Carryforwards
ProceedsFromSaleOfNetOperatingLossCarryforwards
391756 USD
CY2012 ctso Share Based Compensation Arrangement By Share Based Payment Award Nonvested Options Exercised In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonvestedOptionsExercisedInPeriod
CY2012 ctso Share Based Compensation Arrangement By Share Based Payment Award Nonvested Options Exercised In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonvestedOptionsExercisedInPeriodWeightedAverageGrantDateFairValue
CY2012 ctso Share Based Compensation Arrangement By Share Based Payment Award Nonvested Options Forfeited In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonvestedOptionsForfeitedInPeriodWeightedAverageGrantDateFairValue
0.048
CY2012 ctso Share Based Compensation Arrangement By Share Based Payment Award Nonvested Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonvestedOptionsForfeituresInPeriod
4640000
CY2012 ctso Share Based Compensation Arrangement By Share Based Payment Award Nonvested Options Granted In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonvestedOptionsGrantedInPeriodWeightedAverageGrantDateFairValue
0.043
CY2012 ctso Share Based Compensation Arrangement By Share Based Payment Award Nonvested Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonvestedOptionsGrantsInPeriod
1968000
CY2011Q4 ctso Share Based Compensation Arrangement By Share Based Payment Award Nonvested Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonvestedOptionsOutstandingNumber
11910000
CY2012 ctso Share Based Compensation Arrangement By Share Based Payment Award Nonvested Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonvestedOptionsVestedInPeriod
1844000
CY2012 ctso Share Based Compensation Arrangement By Share Based Payment Award Nonvested Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonvestedOptionsVestedInPeriodWeightedAverageGrantDateFairValue
0.048
CY2012Q4 ctso Share Based Compensation Arrangement By Share Based Payment Award Nonvested Options Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonvestedOptionsWeightedAverageGrantDateFairValue
0.05
CY2011Q4 ctso Share Based Compensation Arrangement By Share Based Payment Award Nonvested Options Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonvestedOptionsWeightedAverageGrantDateFairValue
0.051
CY2012 ctso Share Based Compensation Arrangement By Share Based Payment Award Options Cancelled In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCancelledInPeriod
4640000
CY2011 ctso Share Based Compensation Arrangement By Share Based Payment Award Options Cancelled In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCancelledInPeriod
64800
CY2012Q4 ctso Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding And Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableAggregateIntrinsicValue
1369000 USD
CY2012 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2012 dei Trading Symbol
TradingSymbol
ctso
CY2012Q4 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
1150511 USD
CY2011Q4 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
1233626 USD
CY2012 ctso Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Granted In Period Weighted Average Remaining Contractual Term
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingGrantedInPeriodWeightedAverageRemainingContractualTerm
P6Y10M6D
CY2011 ctso Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Granted In Period Weighted Average Remaining Contractual Term
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingGrantedInPeriodWeightedAverageRemainingContractualTerm
P7Y6M
CY2012Q4 ctso Share Based Compensation Arrangements By Share Based Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y1M6D
CY2011Q4 ctso Share Based Compensation Arrangements By Share Based Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y2M12D
CY2010Q4 ctso Share Based Compensation Arrangements By Share Based Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P8Y2M12D
CY2000 ctso Stock Issued During Period Stock And Warrants For Services Or Claims
StockIssuedDuringPeriodStockAndWarrantsForServicesOrClaims
468526 USD
CY2009 ctso Stock Issued During Period Value Conversion Of Convertible Securities Preferred Stock
StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesPreferredStock
-6704 USD
CY2006 ctso Stock Issued During Period Value Merger
StockIssuedDuringPeriodValueMerger
USD
CY2006 ctso Stock Issued During Period Value Merger Note Payable
StockIssuedDuringPeriodValueMergerNotePayable
1000000 USD
CY2012 ctso Stock Issued During Period Value New Issues Preferred Stock
StockIssuedDuringPeriodValueNewIssuesPreferredStock
-2493930 USD
CY2011 ctso Stock Issued During Period Value New Issues Preferred Stock
StockIssuedDuringPeriodValueNewIssuesPreferredStock
-3015023 USD
CY2006 ctso Stock Issued During Period Value New Issues Preferred Stock
StockIssuedDuringPeriodValueNewIssuesPreferredStock
5300000 USD
CY2008 ctso Stock Issued During Period Value New Issues Preferred Stock
StockIssuedDuringPeriodValueNewIssuesPreferredStock
-364747 USD
CY2009 ctso Stock Issued During Period Value New Issues Preferred Stock
StockIssuedDuringPeriodValueNewIssuesPreferredStock
-586023 USD
CY2010 ctso Stock Issued During Period Value New Issues Preferred Stock
StockIssuedDuringPeriodValueNewIssuesPreferredStock
-2008882 USD
CY2006 ctso Stock Issued During Period Value Price Protection
StockIssuedDuringPeriodValuePriceProtection
USD
CY2006 ctso Stock Issued During Period Value Redemption Of Convertible Securities
StockIssuedDuringPeriodValueRedemptionOfConvertibleSecurities
1000000 USD
CY2012 ctso Stock Issued During Period Value Stock Warrants Exercised
StockIssuedDuringPeriodValueStockWarrantsExercised
USD
CY2011 ctso Stock Issued During Period Value Stock Warrants Exercised
StockIssuedDuringPeriodValueStockWarrantsExercised
USD
CY2009 ctso Stock Issued During Period Value Stock Warrants Exercised
StockIssuedDuringPeriodValueStockWarrantsExercised
USD
CY2012 ctso Supplemental Noncash Transactions
SupplementalNoncashTransactions
USD
CY2011 ctso Supplemental Noncash Transactions
SupplementalNoncashTransactions
USD
ctso Supplemental Noncash Transactions
SupplementalNoncashTransactions
768063 USD
CY2012 ctso Technology And Content Expense
TechnologyAndContentExpense
USD
CY2011 ctso Technology And Content Expense
TechnologyAndContentExpense
USD
ctso Technology And Content Expense
TechnologyAndContentExpense
4550000 USD
ctso Technology Contributions
TechnologyContributions
4550000 USD
CY2012 dei Amendment Flag
AmendmentFlag
false
CY2012 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2012 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2012 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2012
CY2012 dei Document Period End Date
DocumentPeriodEndDate
2012-12-31
CY2012 dei Document Type
DocumentType
10-K
CY2012 dei Entity Central Index Key
EntityCentralIndexKey
0001175151
CY2013Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
228948474
CY2012 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2012 dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
CY2012Q2 dei Entity Public Float
EntityPublicFloat
20620000 USD
CY2012 dei Entity Registrant Name
EntityRegistrantName
Cytosorbents Corp
CY2012 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2012Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
800670 USD
CY2011Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
675160 USD
CY2012Q4 us-gaap Accounts Payable Other Current And Noncurrent
AccountsPayableOtherCurrentAndNoncurrent
364285 USD
CY2011Q4 us-gaap Accounts Payable Other Current And Noncurrent
AccountsPayableOtherCurrentAndNoncurrent
374758 USD
CY2012Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
51779 USD
CY2011Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
36078 USD
CY2012Q4 us-gaap Accrued Professional Fees Current And Noncurrent
AccruedProfessionalFeesCurrentAndNoncurrent
177797 USD
CY2011Q4 us-gaap Accrued Professional Fees Current And Noncurrent
AccruedProfessionalFeesCurrentAndNoncurrent
123650 USD
CY2012Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2369240 USD
CY2011Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2339923 USD
CY2012Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-12662 USD
CY2011Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
USD
CY2012Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
86903415 USD
CY2011Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
82288441 USD
CY2012 us-gaap Adjustment For Amortization
AdjustmentForAmortization
25289 USD
CY2011 us-gaap Adjustment For Amortization
AdjustmentForAmortization
15399 USD
us-gaap Adjustment For Amortization
AdjustmentForAmortization
107691 USD
CY2012 us-gaap Adjustment Of Warrants Granted For Services
AdjustmentOfWarrantsGrantedForServices
USD
CY2011 us-gaap Adjustment Of Warrants Granted For Services
AdjustmentOfWarrantsGrantedForServices
USD
us-gaap Adjustment Of Warrants Granted For Services
AdjustmentOfWarrantsGrantedForServices
533648 USD
CY2012 us-gaap Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature
AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
87700 USD
CY2011 us-gaap Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature
AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
1250000 USD
CY2010 us-gaap Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature
AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
306805 USD
CY2006 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
-620563 USD
CY2012 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
63127 USD
CY2011 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
865535 USD
CY2008 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
363563 USD
CY2009 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
236705 USD
CY2010 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
149325 USD
CY2008 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
USD
CY2008 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
40354 USD
CY2012 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
63100 USD
CY2011 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
865500 USD
CY2012Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0 USD
CY2011Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0 USD
CY2012 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
471352 USD
CY2011 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
945434 USD
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
2465729 USD
CY2012 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
USD
CY2011 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
183556 USD
CY2012Q4 us-gaap Assets
Assets
3339408 USD
CY2011Q4 us-gaap Assets
Assets
2122542 USD
CY2012Q4 us-gaap Assets Current
AssetsCurrent
2939588 USD
CY2011Q4 us-gaap Assets Current
AssetsCurrent
1697481 USD
CY2012Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
399820 USD
CY2011Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
425061 USD
CY2012 us-gaap Basis Of Accounting
BasisOfAccounting
<!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <strong>1. BASIS OF PRESENTATION</strong></p> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> The accompanying consolidated financial statements include the results of CytoSorbents Corporation (the "Parent"), CytoSorbents, Inc. its wholly-owned operating subsidiary (the "Subsidiary"), and CytoSorbents Europe GmbH, its wholly-owned European subsidiary (the "European Subsidiary"), collectively referred to as "the Company."</p> <p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> The accompanying consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and satisfaction of liabilities in the normal course of business. The Company has experienced negative cash flows from operations since inception and has a deficit accumulated during the development stage at December 31, 2012 of $98,732,460. The Company is not currently generating significant revenue and is dependent on the proceeds of present and future financings to fund its research, development and commercialization program. The Company is continuing its fund-raising efforts. Although the Company has historically been successful in raising additional capital through equity and debt financings, there can be no assurance that the Company will be successful in raising additional capital in the future or that it will be on favorable terms. Furthermore, if the Company is successful in raising the additional financing, there can be no assurance that the amount will be sufficient to complete the Company&#39;s plans. These matters raise substantial doubt about the Company&#39;s ability to continue as a going concern. These consolidated financial statements do not include any adjustments related to the outcome of this uncertainty.</p> <p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> The Company is a development stage company and has not yet generated significant revenues. Since inception, the Company&#39;s expenses relate primarily to research and development, organizational activities, clinical manufacturing, regulatory compliance and operational strategic planning. Although the Company has made advances on these matters, there can be no assurance that the Company will continue to be successful regarding these issues, nor can there be any assurance that the Company will successfully implement its long-term strategic plans.</p> <p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> The Company has developed an intellectual property portfolio, including 32 issued and multiple pending patents, covering materials, methods of production, systems incorporating the technology and multiple medical uses.</p> <!--EndFragment--></div> </div>
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1729344 USD
CY2011Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1186653 USD
CY2010Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1055669 USD
CY1997Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
USD
CY2012 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
542691 USD
CY2011 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
130984 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
1729344 USD
CY2012Q4 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
890000
CY2012Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
22307046
CY2012Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2011Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2012Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2011Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2012Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000
CY2011Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000
CY2012Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
214967503
CY2011Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
177626058
CY2012Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
214967503
CY2011Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
177626058
CY2012Q4 us-gaap Common Stock Value
CommonStockValue
214968 USD
CY2011Q4 us-gaap Common Stock Value
CommonStockValue
177626 USD
CY2012 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-3676168 USD
CY2011 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-5481648 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-88370405 USD
CY2012 us-gaap Conversion Of Stock Amount Issued1
ConversionOfStockAmountIssued1
USD
CY2011 us-gaap Conversion Of Stock Amount Issued1
ConversionOfStockAmountIssued1
USD
CY2012 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <strong>Concentration of Credit Risk</strong></p> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> The Company maintains cash balances, at times, with financial institutions in excess of amounts insured by the Federal Deposit Insurance Corporation. Management monitors the soundness of these institutions in an effort to minimize its collection risk of these balances.</p> <!--EndFragment--></div> </div>
CY2012 us-gaap Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
USD
CY2011 us-gaap Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
USD
us-gaap Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
559 USD
us-gaap Conversion Of Stock Amount Issued1
ConversionOfStockAmountIssued1
399395 USD
CY2012Q4 us-gaap Convertible Debt Fair Value Disclosures
ConvertibleDebtFairValueDisclosures
612300 USD
CY2011Q4 us-gaap Convertible Debt Fair Value Disclosures
ConvertibleDebtFairValueDisclosures
0 USD
CY2012Q4 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
USD
CY2011Q4 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
276250 USD
CY2012Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
926225 USD
CY2011Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
294323 USD
CY2012 us-gaap Cost Of Goods Sold
CostOfGoodsSold
319298 USD
CY2011 us-gaap Cost Of Goods Sold
CostOfGoodsSold
11760 USD
us-gaap Cost Of Goods Sold
CostOfGoodsSold
833871 USD
CY2012 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
USD
CY2011 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
1515130 USD
us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
11949449 USD
CY2012 us-gaap Debt Conversion Converted Instrument Shares Issued1
DebtConversionConvertedInstrumentSharesIssued1
989103
CY2011 us-gaap Debt Conversion Converted Instrument Shares Issued1
DebtConversionConvertedInstrumentSharesIssued1
1515130
CY2012 us-gaap Debt Instrument Convertible Beneficial Conversion Feature
DebtInstrumentConvertibleBeneficialConversionFeature
48912 USD
CY2011 us-gaap Debt Instrument Convertible Beneficial Conversion Feature
DebtInstrumentConvertibleBeneficialConversionFeature
783568 USD
CY2012Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
235590 USD
CY2011Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
425427 USD
CY2012 us-gaap Depreciation
Depreciation
29316 USD
CY2011 us-gaap Depreciation
Depreciation
23751 USD
us-gaap Depreciation
Depreciation
2396328 USD
CY2012 us-gaap Depreciation And Amortization
DepreciationAndAmortization
54606 USD
CY2011 us-gaap Depreciation And Amortization
DepreciationAndAmortization
39150 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
2504021 USD
CY2012Q4 us-gaap Development Stage Enterprise Deficit Accumulated During Development Stage
DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage
98732460 USD
CY2011Q4 us-gaap Development Stage Enterprise Deficit Accumulated During Development Stage
DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage
92557542 USD
CY2012 us-gaap Dividends Preferred Stock Stock
DividendsPreferredStockStock
USD
CY2011 us-gaap Dividends Preferred Stock Stock
DividendsPreferredStockStock
USD
CY2006 us-gaap Dividends Preferred Stock Stock
DividendsPreferredStockStock
USD
CY2008 us-gaap Dividends Preferred Stock Stock
DividendsPreferredStockStock
USD
CY2009 us-gaap Dividends Preferred Stock Stock
DividendsPreferredStockStock
USD
CY2010 us-gaap Dividends Preferred Stock Stock
DividendsPreferredStockStock
USD
CY2012 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.03
CY2011 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.05
CY2012 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
CY2011 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
CY2012 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
-0.34
CY2011 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
-0.34
CY2012 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.288
CY2011 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.25
CY2012 us-gaap Effective Income Tax Rate Reconciliation Equity In Earnings Losses Of Unconsolidated Subsidiary
EffectiveIncomeTaxRateReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary
0.008
CY2011 us-gaap Effective Income Tax Rate Reconciliation Equity In Earnings Losses Of Unconsolidated Subsidiary
EffectiveIncomeTaxRateReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary
0.031
CY2012 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
0.044
CY2011 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
0.059
CY2012 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
CY2011 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
CY2012 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-12662 USD
CY2011 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
USD
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-12662 USD
CY2012Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
54103 USD
CY2011 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
USD
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
21663 USD
CY2012 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
USD
CY2011 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
216617 USD
CY2012Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
25000 USD
CY2012Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
25000 USD
CY2012Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
25000 USD
CY2012Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
25000 USD
CY2012Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
25000 USD
CY2012 us-gaap Freight Costs
FreightCosts
65000 USD
CY2011 us-gaap Freight Costs
FreightCosts
14000 USD
CY2012 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
USD
CY2012 us-gaap Gross Profit
GrossProfit
1023638 USD
CY2011 us-gaap Gross Profit
GrossProfit
24318 USD
us-gaap Gross Profit
GrossProfit
1545588 USD
CY2012 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-4055262 USD
CY2011 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-5481648 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-88749499 USD
CY2012 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-391756 USD
CY2011 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
USD
CY2011 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
36078 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-939074 USD
CY2012 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
147948 USD
CY2011 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-30706 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
3105804 USD
CY2012 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
15701 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
51779 USD
CY2012 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
USD
CY2011 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
USD
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
1823103 USD
CY2012 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
251350 USD
CY2011 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
431022 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
682372 USD
CY2012 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-9441 USD
CY2011 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
USD
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
46953 USD
CY2012 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
432365 USD
CY2011 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-300808 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
747641 USD
CY2012 us-gaap Interest Expense Debt
InterestExpenseDebt
235762 USD
CY2011 us-gaap Interest Expense Debt
InterestExpenseDebt
516258 USD
CY2012 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-564428 USD
CY2011 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-1044881 USD
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-7301550 USD
CY2012 us-gaap Interest Paid
InterestPaid
USD
CY2011 us-gaap Interest Paid
InterestPaid
USD
us-gaap Interest Paid
InterestPaid
590189 USD
CY2012Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
438790 USD
CY2011Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
191340 USD
CY2012Q4 us-gaap Inventory Net
InventoryNet
682372 USD
CY2011Q4 us-gaap Inventory Net
InventoryNet
431022 USD
CY2012Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
48702 USD
CY2011Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
0 USD
CY2012Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
194880 USD
CY2011Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
239682 USD
CY2012 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
USD
CY2011 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
USD
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
30000 USD
CY2012 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
334000 USD
CY2011 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
249000 USD
CY2012Q4 us-gaap Liabilities
Liabilities
2076736 USD
CY2011Q4 us-gaap Liabilities
Liabilities
1804199 USD
CY2012Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3339408 USD
CY2011Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2122542 USD
CY2012Q4 us-gaap Liabilities Current
LiabilitiesCurrent
2076736 USD
CY2011Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1527949 USD
CY2012Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
USD
CY2011Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
276250 USD
CY2012 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
4210606 USD
CY2011 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
4012001 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
72454863 USD
CY2012 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-38806 USD
CY2011 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-52490 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-4519001 USD
CY2012 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3616447 USD
CY2011 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3828527 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-66193856 USD
CY2012 us-gaap Net Income Loss
NetIncomeLoss
-3663506 USD
CY2011 us-gaap Net Income Loss
NetIncomeLoss
-5481648 USD
us-gaap Net Income Loss
NetIncomeLoss
-87810425 USD
us-gaap Net Income Loss
NetIncomeLoss
-5256012 USD
CY1998 us-gaap Net Income Loss
NetIncomeLoss
-1867348 USD
CY1999 us-gaap Net Income Loss
NetIncomeLoss
-3066388 USD
CY2000 us-gaap Net Income Loss
NetIncomeLoss
-10753871 USD
CY2001 us-gaap Net Income Loss
NetIncomeLoss
-15392618 USD
CY2002 us-gaap Net Income Loss
NetIncomeLoss
-11871668 USD
CY2012 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-12662 USD
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
29273
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
190783
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
1968000
CY2011 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
290000
CY2003 us-gaap Net Income Loss
NetIncomeLoss
-6009283 USD
CY2004 us-gaap Net Income Loss
NetIncomeLoss
-1096683 USD
CY2005 us-gaap Net Income Loss
NetIncomeLoss
-3665596 USD
CY2006 us-gaap Net Income Loss
NetIncomeLoss
-7671580 USD
CY2007 us-gaap Net Income Loss
NetIncomeLoss
-3350754 USD
CY2008 us-gaap Net Income Loss
NetIncomeLoss
-3017890 USD
CY2009 us-gaap Net Income Loss
NetIncomeLoss
-2736715 USD
CY2010 us-gaap Net Income Loss
NetIncomeLoss
-2908865 USD
CY2012 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-6174918 USD
CY2011 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-8568692 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-98732460 USD
CY2012 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-564428 USD
CY2011 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1044881 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-7424765 USD
CY2012 us-gaap Operating Expenses
OperatingExpenses
4514472 USD
CY2011 us-gaap Operating Expenses
OperatingExpenses
4461085 USD
us-gaap Operating Expenses
OperatingExpenses
82870322 USD
CY2012 us-gaap Operating Income Loss
OperatingIncomeLoss
-3490834 USD
CY2011 us-gaap Operating Income Loss
OperatingIncomeLoss
-4436767 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-81324734 USD
CY2012Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
89400 USD
CY2012Q4 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
86700 USD
CY2012Q4 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
2700 USD
CY2012Q4 us-gaap Other Accrued Liabilities Current And Noncurrent
OtherAccruedLiabilitiesCurrentAndNoncurrent
608429 USD
CY2011Q4 us-gaap Other Accrued Liabilities Current And Noncurrent
OtherAccruedLiabilitiesCurrentAndNoncurrent
735218 USD
CY2012 us-gaap Other Amortization Of Deferred Charges
OtherAmortizationOfDeferredCharges
USD
CY2011 us-gaap Other Amortization Of Deferred Charges
OtherAmortizationOfDeferredCharges
USD
us-gaap Other Amortization Of Deferred Charges
OtherAmortizationOfDeferredCharges
74938 USD
CY2012Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
254220 USD
CY2011Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
269994 USD
CY2011 us-gaap Other Operating Income
OtherOperatingIncome
USD
us-gaap Other Operating Income
OtherOperatingIncome
6055483 USD
CY2012 us-gaap Paid In Kind Interest
PaidInKindInterest
USD
CY2011 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
34672 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2420810 USD
CY2012Q4 us-gaap Preferred Stock Capital Shares Reserved For Future Issuance
PreferredStockCapitalSharesReservedForFutureIssuance
15600000
CY2012 us-gaap Other Noncash Expense
OtherNoncashExpense
USD
CY2011 us-gaap Other Noncash Expense
OtherNoncashExpense
USD
CY2012 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
2511412 USD
CY2011 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
USD
us-gaap Other Noncash Expense
OtherNoncashExpense
361496 USD
CY2012 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
USD
CY2011 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
USD
us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
361495 USD
CY2012 us-gaap Other Operating Income
OtherOperatingIncome
USD
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-12662 USD
CY2012 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-12662 USD
CY2012 us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
-3100000 USD
CY2011 us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
-4500000 USD
CY2012Q4 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
207267 USD
CY2011Q4 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
213600 USD
CY2011 us-gaap Paid In Kind Interest
PaidInKindInterest
USD
us-gaap Paid In Kind Interest
PaidInKindInterest
3147 USD
CY2012 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
18956 USD
CY2011 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
17818 USD
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
498514 USD
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
393607 USD
CY2012 us-gaap Payments To Acquire Loans Receivable
PaymentsToAcquireLoansReceivable
USD
CY2011 us-gaap Payments To Acquire Loans Receivable
PaymentsToAcquireLoansReceivable
USD
us-gaap Payments To Acquire Loans Receivable
PaymentsToAcquireLoansReceivable
1632168 USD
CY2012 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
19850 USD
CY2011 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
3087044 USD
us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
10922035 USD
CY2012Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
1.0
CY2012Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000
CY2012Q4 us-gaap Preferred Stock Value
PreferredStockValue
1594 USD
CY2011Q4 us-gaap Preferred Stock Value
PreferredStockValue
1447 USD
CY2012Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
476093 USD
CY2011Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
43728 USD
CY2012 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
USD
CY2011 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
USD
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
32491 USD
CY2012 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
10605 USD
CY2011Q4 us-gaap Security Deposit
SecurityDeposit
56394 USD
CY2012 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1354738 USD
CY2011 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1230189 USD
us-gaap Proceeds From Contributed Capital
ProceedsFromContributedCapital
50071311 USD
CY2012 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
USD
CY2011 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
400490 USD
CY2012 us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
USD
CY2011 us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
USD
CY2012 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <strong>Reclassification</strong></p> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <strong>&nbsp;</strong></p> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <font style="FONT-FAMILY: Times New Roman, Times, Serif">Certain reclassifications have been made to the prior years&#39; consolidated financial statements and related</font>&nbsp; <font style="FONT-FAMILY: Times New Roman, Times, Serif">notes to conform to the current year presentation.</font></p> <p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <strong>&nbsp;</strong></p> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <font style="FONT-STYLE: normal; FONT-FAMILY: Times New Roman, Times, Serif"> During 2012, the Company re-examined its accounting treatment related to the Series B Preferred Stock under</font>&nbsp; <font style="FONT-STYLE: normal; FONT-FAMILY: Times New Roman, Times, Serif"> FASB guidance and determined that the Series B Preferred Stock should be classified as temporary equity in the balance sheet, as reflected in the financial statements included herein. The Company also determined that the Series B Preferred Stock was initially reported at its fair value and that as the security is not currently redeemable and it is not probable that the security will become redeemable, because the resolution of the contingencies discussed in Note 10 that would allow redemption have not occurred, subsequent adjustment as December 31, 2012 is not necessary. The reclassification has no impact on net income for any period presented in these financial statements.</font></p> <!--EndFragment--></div> </div>
CY2012 us-gaap Proceeds From Contributed Capital
ProceedsFromContributedCapital
3500001 USD
CY2011 us-gaap Proceeds From Contributed Capital
ProceedsFromContributedCapital
2756860 USD
us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
9579040 USD
CY2012 us-gaap Proceeds From Other Debt
ProceedsFromOtherDebt
700000 USD
CY2011 us-gaap Proceeds From Other Debt
ProceedsFromOtherDebt
1250000 USD
us-gaap Proceeds From Other Debt
ProceedsFromOtherDebt
11888881 USD
CY2012 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
USD
CY2011 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
USD
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
499395 USD
CY2012 us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
USD
CY2011 us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
USD
us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
393607 USD
CY2011 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
5141 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
15746 USD
CY2012 us-gaap Professional Fees
ProfessionalFees
627245 USD
CY2011 us-gaap Professional Fees
ProfessionalFees
342651 USD
us-gaap Professional Fees
ProfessionalFees
8585135 USD
CY2012Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
2514840 USD
CY2011Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
2494990 USD
CY2012Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
145600 USD
CY2011Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
155067 USD
CY2012 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
USD
CY2011 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
255882 USD
CY2012 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2532489 USD
CY2011 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2888245 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
53929459 USD
CY2012 us-gaap Revenue From Grants
RevenueFromGrants
1191362 USD
CY2011 us-gaap Revenue From Grants
RevenueFromGrants
USD
us-gaap Revenue From Grants
RevenueFromGrants
2191807 USD
CY2012 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
151574 USD
CY2011 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
36078 USD
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
187652 USD
CY2012 us-gaap Sales Revenue Net
SalesRevenueNet
1342936 USD
CY2011 us-gaap Sales Revenue Net
SalesRevenueNet
36078 USD
us-gaap Sales Revenue Net
SalesRevenueNet
2379459 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
26411211 USD
CY2012 us-gaap Service Management Costs
ServiceManagementCosts
USD
CY2011 us-gaap Service Management Costs
ServiceManagementCosts
USD
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0.05
CY2011 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0.055
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
36667616
CY2012Q4 us-gaap Security Deposit
SecurityDeposit
46953 USD
CY2011Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
39833438
CY2010Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
39755113
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.23
CY2011Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.39
CY2010Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.44
CY2012 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.04
CY2011 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.035
CY2012 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
34.72
CY2012 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
0.14
CY2011 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
31.52
CY2012 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.15
CY2011 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.137
CY2012Q4 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
0.26
CY2012 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
0.04
CY2012 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
41.47
CY2012Q4 us-gaap Stockholders Equity
StockholdersEquity
-11625145 USD
CY2011Q4 us-gaap Stockholders Equity
StockholdersEquity
-10090028 USD
CY2010Q4 us-gaap Stockholders Equity
StockholdersEquity
-8065391 USD
CY1997Q1 us-gaap Stockholders Equity
StockholdersEquity
USD
CY1997Q4 us-gaap Stockholders Equity
StockholdersEquity
877475 USD
CY1998Q4 us-gaap Stockholders Equity
StockholdersEquity
1580034 USD
CY2006Q4 us-gaap Stockholders Equity
StockholdersEquity
2363005 USD
CY2007Q4 us-gaap Stockholders Equity
StockholdersEquity
-104296 USD
CY2008Q4 us-gaap Stockholders Equity
StockholdersEquity
-3345733 USD
CY2009Q4 us-gaap Stockholders Equity
StockholdersEquity
-5742027 USD
CY2001 us-gaap Stockholders Equity Other
StockholdersEquityOther
1206730 USD
CY2002 us-gaap Stockholders Equity Other
StockholdersEquityOther
556047 USD
CY2003 us-gaap Stockholders Equity Other
StockholdersEquityOther
343737 USD
CY2004 us-gaap Stockholders Equity Other
StockholdersEquityOther
80218 USD
CY2008 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
0 USD
CY2009 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
681558 USD
CY2010 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
1437814 USD
CY2012 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
3660153 USD
CY2011 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
2643766 USD
CY1999Q4 us-gaap Stockholders Equity
StockholdersEquity
100548 USD
CY2000Q4 us-gaap Stockholders Equity
StockholdersEquity
5340631 USD
CY2001Q4 us-gaap Stockholders Equity
StockholdersEquity
2329208 USD
CY2002Q4 us-gaap Stockholders Equity
StockholdersEquity
-4374976 USD
CY2003Q4 us-gaap Stockholders Equity
StockholdersEquity
-3907307 USD
CY2004Q4 us-gaap Stockholders Equity
StockholdersEquity
-6967944 USD
CY2005Q4 us-gaap Stockholders Equity
StockholdersEquity
-9760207 USD
CY2005 us-gaap Stockholders Equity Other
StockholdersEquityOther
92287 USD
CY2012 us-gaap Stock Issued1
StockIssued1
247536 USD
CY2011 us-gaap Stock Issued1
StockIssued1
106344 USD
us-gaap Stock Issued1
StockIssued1
583486 USD
CY2012 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
303039
CY2011 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
146875
CY2012 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
14484 USD
CY2011 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
187462 USD
CY2006 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
USD
CY2007 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
USD
CY2006 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
799885 USD
CY2010 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
749999 USD
CY2010 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
-49560 USD
CY2011 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
5141 USD
CY2012 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
63128 USD
CY2011 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
865535 USD
us-gaap Stock Option Plan Expense
StockOptionPlanExpense
2568188 USD
CY2012 us-gaap Use Of Estimates
UseOfEstimates
<!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <strong>Use of Estimates</strong></p> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities. Actual results could differ from these estimates. Significant estimates in these financials are the valuation of options granted and the valuation of preferred shares issued as stock dividends.</p> <!--EndFragment--></div> </div>
CY2012Q4 us-gaap Warrants Not Settleable In Cash Fair Value Disclosure
WarrantsNotSettleableInCashFairValueDisclosure
38788 USD
CY2011Q4 us-gaap Warrants Not Settleable In Cash Fair Value Disclosure
WarrantsNotSettleableInCashFairValueDisclosure
466432 USD
CY2012 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
198228289
CY2011 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
160235291

Files In Submission

Name View Source Status
0001144204-13-019816-index-headers.html Edgar Link pending
0001144204-13-019816-index.html Edgar Link pending
0001144204-13-019816.txt Edgar Link pending
0001144204-13-019816-xbrl.zip Edgar Link pending
ctso-20121231.xml Edgar Link completed
ctso-20121231.xsd Edgar Link pending
ctso-20121231_cal.xml Edgar Link unprocessable
ctso-20121231_def.xml Edgar Link unprocessable
ctso-20121231_lab.xml Edgar Link unprocessable
ctso-20121231_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
v337555_10k.htm Edgar Link pending
v337555_ex31-1.htm Edgar Link pending
v337555_ex31-2.htm Edgar Link pending
v337555_ex32-1.htm Edgar Link pending
v337555_ex32-2.htm Edgar Link pending